期刊文献+

甲基化抑制剂对肾癌细胞株中γ-caenin蛋白表达的影响 被引量:1

Expression of γ-catenin protein and its methylation regulation in human renal carcinoma line A498
下载PDF
导出
摘要 目的研究甲基化抑制剂5-氮杂-2'-脱氧胞苷(5-Aza-CdR)对人肾痛A498细胞增殖及γ-连环蛋白(γ-catenin)表达的影响。方法使用不同浓度(10^(-7)、10^(-6)、10^(-5)mol/L)的特异性DNA甲基转移酶抑制剂5-Aza-CdR处理A498肾癌细胞株。MTT检测5-Aza-CdR对肾癌细胞株A498抑制作用。细胞免疫化学检测5-Aza-CdR处理A498肾癌细胞株后γ-catenin表达的变化。结果 5-Aza-CdR能明显抑制肾癌细胞的增殖,且与药物浓度及作用时间有关。药物处理后y-连环蛋白表达增加。结论 y-catenin蛋白表达受甲基化的抑制,提示5-Aza-CdR可使γ-catenm基因去甲基化而抑制A498肾癌细胞株增殖。 Objective To investigate the effect of methylation inhibitor 5 - Aza - 2' - deoxycytidine on the growth of human renal cancer cell line A498 and γ- catenin expression. Methods Human renal carcinoma A498 ceUs were treated with different concentrations of 5 - Aza - CdR( 10 -7,10 -6,10 -5 mol/L) respecttively. Then the growth rate of the ceils was detected by MTT assay. The immuneocytochemistry was used to detect γ - catenin levels in the cell line before and after treatment with 5 - Aza - CdR. Results 5 - Aza - CdR can inhibit the growth of A498 cells, 7 - catenin expression levels in A498 ceils were increased after 5 - Aza - CdR treatment. Conclusion γ - catenin expression levels were inhibited by methylation, 5 - Aza - CdR can inhibit the growth of A498 cells by inducing demethylation in the promoter region of γ - catenin gene.
出处 《中国医学创新》 CAS 2011年第36期19-20,共2页 Medical Innovation of China
关键词 5-氮杂-2’-脱氧胞苷 肾癌A498细胞株 Γ-连环蛋白 免疫组化 5 - Aza - 2' - deoxyeytidine A498 cell lines γ - catenin lmmunocytochemistry
  • 相关文献

参考文献3

二级参考文献107

  • 1张卫强,王云杰,林华,周勇安,程庆书,刘锟,李小飞,王小平.N-cadherin在非小细胞肺癌组织中的表达及临床生物学意义[J].第四军医大学学报,2005,26(2):157-159. 被引量:4
  • 2[1]Tamura G,Kihana T,Nomura K,Terada M,Sugimura T,Hirohashi S.Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.Cancer Res 1991; 51:3056-3058
  • 3[2]Becker KF,Atkinson MJ,Reich U,Becker I,Nekarda H,Siewert JR,Hofler H.E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.Cancer Res 1994; 54:3845-3852
  • 4[3]Tamura G,Sakata K,Nishizuka S,Maesawa C,Suzuki Y,Iwaya T,Terashima M,Saito K,Satodate R.Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.Jpn J Cancer Res 1996; 87:1153-1159
  • 5[4]Kim IJ,Kang HC,Shin Y,Park HW,Jang SG,Han SY,Lim SK,Lee MR,Chang HJ,Ku JL,Yang HK,Park JG.A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and LiFraumeni syndrome.J Hum Genet 2004; 49:591-595
  • 6[5]Guilford P,Hopkins J,Harraway J,McLeod M,McLeod N,Harawira P,Taite H,Scoular R,Miller A,Reeve AE.E-cadherin germline mutations in familial gastric cancer.Nature 1998; 392:402-405
  • 7[6]Tamura G,Yin J,Wang S,Fleisher AS,Zou T,Abraham JM,Kong D,Smolinski KN,Wilson KT,James SP,Silverberg SG,Nishizuka S,Terashima M,Motoyama T,Meltzer SJ.E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.JNatl Cancer Inst 2000; 92:569-573
  • 8[7]Nishizuka S,Tamura G,Terashima M,Satodate R.Loss of heterozygosity during development and progression of differentiated adenocarcinoma of the stomach.J Pathol 1998;185:3843
  • 9[8]Akiyama Y,Nakasaki H,Nihei Z,Iwama T,Nomizu T,Utsunomiya J,Yuasa Y.Frequent microsatellite instabilities and analyses of the related genes in familial gastric cancers.Jpn J Cancer Res 1996; 87:595-601
  • 10[9]Semba S,Yokozaki H,Yasui W,Tahara E.Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer.Int J Oncol 1998; 12:1245-1251

共引文献114

同被引文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部